Open access
Jul 2026
Integrating machine learning and structure-based simulations to prioritise Z4P as a mutation-resilient IRE1α inhibitor for breast cancer.
Findings highlight Z4P as a promising mutation-resilient IRE1 inhibitor and validate the effectiveness of the integrated computational pipeline for identifying potential anti-cancer therapeutics.
Nithisha L Bastin, P. K. Praveen Kumar, B. Ethiraj et al.
· Scientific Reports · 0 citations